产品详情

参考资料（来源文献）

相关文献

• Tumor ABCC4-mediated release of PGE2 induces CD8+ T cell dysfunction and impairs PD-1 blockade in prostate cancer(2024)

  期刊：International Journal of Biological Sciences

  DOI：10.7150/ijbs.99716

  影响因子：8.2

  相关产品： RM-1 Cells Line

• Identification of diagnostic biomarkers in prostate cancer-related fatigue by construction of predictive models and experimental validation(2024)

  期刊：BRITISH JOURNAL OF CANCER

  DOI：10.1038/s41416-024-02922-1

  影响因子：6.4

  相关产品： RM-1 Cells Line

• The glycolysis-related AMPK/ULK signaling pathway mediates the inhibitory effect of adiponectin in prostate cancer cells(2024)

  期刊：MOLECULAR AND CELLULAR ENDOCRINOLOGY

  DOI：10.1016/j.mce.2024.112338

  影响因子：3.8

  相关产品： RM-1 Cells Line, PC-3 Cells Line, LNCaP clone FGC Cells Line

• Overcoming the On-Target Toxicity in Antibody-Mediated Therapies via an Indirect Active Targeting Strategy(2023)

  期刊：Advanced Science

  DOI：10.1002/advs.202206912

  影响因子：15.100

  相关产品： PE Anti-Human/Mouse/Rat CD47 Antibody, 4T1 Cells Line, MCF7 [MCF-7] Cells Line, A549 [A-549] Cells Line, A20 Cells Line, RM-1 Cells Line, NCI-N87 [N87] Cells Line, TE-1 Cells Line, P388D1 Cells Line, HPAC Cells Line

• Delivery of Mrna Vaccine with 1, 2-diesters-derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy.(2023)

  期刊：Advanced Healthcare Materials

  DOI：10.1002/adhm.202302691

  影响因子：10.0

  相关产品： B16 Cells Line, RM-1 Cells Line, DC2.4 Cells Line, 293 [HEK-293] Cells Line

• JUN and ATF3 are deficient in prostate cancer patients and their delivery in vivo via lipid nanoparticles has therapeutic efficacy by enhancing immune surveillance(2023)

  期刊：PHARMACOLOGICAL RESEARCH

  DOI：10.1016/j.phrs.2023.106753

  影响因子：9.300

  相关产品： RM-1 Cells Line

• A Pegylated Liposome Loaded with Raddeanin A for Prostate Cancer Therapy(2023)

  期刊：International Journal of Nanomedicine

  DOI：10.2147/IJN.S420803

  影响因子：8.0

  相关产品： 22RV1 Cells Line, RM-1 Cells Line

• Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer(2023)

  期刊：Journal of Immunology Research

  DOI：10.1155/2023/2473075

  影响因子：4.1

  相关产品： RM-1 Cells Line

• Voluntarily wheel running inhibits the growth of CRPC xenograft by inhibiting HMGB1 in mice(2023)

  期刊：EXPERIMENTAL GERONTOLOGY

  DOI：10.1016/j.exger.2023.112118

  影响因子：3.900

  相关产品： RM-1 Cells Line

• Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis(2022)

  期刊：Microbiome

  DOI：10.1186/s40168-022-01289-w

  影响因子：15.500

  相关产品： RM-1 Cells Line

产品推荐